BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 38664756)

  • 1. Surgical Informed Consent in Clinical Practice: Patients' Perspective Undergoing Cesarean Section at Three Teaching Hospitals in Addis Ababa, Ethiopia.
    Kebede E; Tasew T; Worku D
    Ethiop J Health Sci; 2023 Jul; 33(4):671-680. PubMed ID: 38784215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoid preponderance and the absence of basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leukemia.
    Hur M; Song EY; Kang SH; Shin DH; Kim JY; Park SS; Cho HI
    Ann Hematol; 2002 Apr; 81(4):219-23. PubMed ID: 11976825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis.
    Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H
    Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematological, clinical, cytogenetic and molecular profiles of confirmed chronic myeloid leukemia patients at presentation at a tertiary care teaching hospital in Addis Ababa, Ethiopia: a cross-sectional study.
    Urgessa F; Lengiso B; Tsegaye A; Gebremedhin A; Abdella F; Tadesse F; Radich J; Nigussie H; Kuru Gerbaba T
    BMC Cancer; 2024 Apr; 24(1):530. PubMed ID: 38664756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients.
    Hailemariam TS; Mehdi M; Kinde S; Seifu D; Edao A
    Recent Pat Anticancer Drug Discov; 2021; 16(3):445-455. PubMed ID: 33618649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.
    Anand MS; Varma N; Varma S; Rana KS; Malhotra P
    Indian J Med Res; 2012; 135(1):42-8. PubMed ID: 22382182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of BCR/ABL Fusion Gene by Hematological and Cytogenetical Analysis in Chronic Myeloid Leukemia Patients in Quetta, Pakistan.
    Tahira B; Asif M; Khan S; Hussain A; Shahwani MN; Malik A; Inayatullah S; Iqbal Z; Rasool M
    Asian Pac J Cancer Prev; 2015; 16(9):3793-7. PubMed ID: 25987039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
    Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
    Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinician perspective on the treatment of chronic myeloid leukemia in the chronic phase.
    García-Gutiérrez V; Breccia M; Jabbour E; Mauro M; Cortes JE
    J Hematol Oncol; 2022 Jul; 15(1):90. PubMed ID: 35818053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia.
    Tadesse F; Asres G; Abubeker A; Gebremedhin A; Radich J
    JCO Glob Oncol; 2021 Jul; 7():1187-1193. PubMed ID: 34292760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future.
    Minciacchi VR; Kumar R; Krause DS
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early molecular response in East African Philadelphia chromosome-positive chronic myeloid leukaemia patients treated with Imatinib and barriers to access treatment.
    Henke O; Mapendo PJ; Mkwizu EW; le Coutre P
    Ecancermedicalscience; 2020; 14():1089. PubMed ID: 33014131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Transcript-Type
    Molica M; Abruzzese E; Breccia M
    Mediterr J Hematol Infect Dis; 2020; 12(1):e2020062. PubMed ID: 32952973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia.
    Smith G; Apperley J; Milojkovic D; Cross NCP; Foroni L; Byrne J; Goringe A; Rao A; Khorashad J; de Lavallade H; Mead AJ; Osborne W; Plummer C; Jones G; Copland M;
    Br J Haematol; 2020 Oct; 191(2):171-193. PubMed ID: 32734668
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.